ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,258Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 434

$599K Total Retail Price of All Prescriptions

Rank: 24 out of 434

731 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 731 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 731 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,259 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 700 601 1 1
LEVOTHYROXINE SODIUM 492 388 2 3
SIMVASTATIN 486 458 3 2
LOVASTATIN 423 353 4 10
HYDROCODONE-ACETAMINOPHEN 421 347 S3 5 4
METFORMIN HCL 353 302 6 7
OMEPRAZOLE 348 273 7 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 322 282 8 21
METOPROLOL SUCCINATE 322 304 8 22
ATORVASTATIN CALCIUM 311 252 10 19
ALENDRONATE SODIUM 294 279 11 15
WARFARIN SODIUM 293 273 12 18
AMLODIPINE BESYLATE 284 248 13 6
METOPROLOL TARTRATE 267 229 14 12
ZOLPIDEM TARTRATE 261 210 15 11
FUROSEMIDE 233 205 16 9
GABAPENTIN 168 127 17 14
DONEPEZIL HCL 143 136 18 35
TAMSULOSIN HCL 140 137 19 29
ATENOLOL 124 93 20 16
HYDRALAZINE HCL 116 113 21 79
PRAVASTATIN SODIUM 114 94 22 17
HYDROCHLOROTHIAZIDE 111 94 23 8
LOSARTAN POTASSIUM 110 105 24 13
DILTIAZEM 24HR CD 107 107 25 126
AZITHROMYCIN 107 92 25 38
POTASSIUM CHLORIDE 101 84 27 20
TRAMADOL HCL 98 83 28 28
LOSARTAN-HYDROCHLOROTHIAZIDE 95 93 29 39
CARVEDILOL 93 88 30 24
SPIRONOLACTONE 88 71 31 70
CIPROFLOXACIN HCL 87 76 32 55
CLOPIDOGREL 79 70 33 41
GLIPIZIDE 79 73 33 37
CLONIDINE HCL 73 62 35 63
ISOSORBIDE MONONITRATE ER 72 66 36 68
AMITRIPTYLINE HCL 68 49 R 37 57
SPIRIVA 68 61 37 36
RANITIDINE HCL 68 46 37 31
PROVENTIL HFA 68 44 37 179
ALLOPURINOL 67 53 41 25
LABETALOL HCL 65 54 42 174
NIFEDIPINE ER 65 65 42 86
MELOXICAM 64 41 44 46
DIGOXIN 64 53 44 69
PLAVIX 58 49 46 64
TERAZOSIN HCL 56 49 47 40
LANTUS SOLOSTAR 54 49 48 71
PENTOXIFYLLINE 54 54 48 279
VYTORIN 53 42 50 169
TIZANIDINE HCL 53 29 50 88
GLYBURIDE 51 51 R 52 51
FLUOXETINE HCL 50 41 53 32
OXYCODONE HCL-ACETAMINOPHEN 50 21 S2 53 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.